Walgreen explores sale of $1.5 bln infusion business -sources

NEW YORK, Sept 23 (Reuters) - U.S. drugstore chain operator Walgreen Co is exploring the sale of a majority stake in its infusion services business, in a deal that could value that division at around $1.5 billion, according to four people familiar with the matter.